11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome

The metabolic syndrome describes a clustering of risk factors—visceral obesity, dyslipidaemia, insulin resistance, and salt-sensitive hypertension—that increases mortality related to cardiovascular disease, type 2 diabetes, cancer, and non-alcoholic fatty liver disease. The prevalence of these concu...

Descripción completa

Detalles Bibliográficos
Autor principal: Bailey, Matthew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Hypertension and Metabolic Syndrome (J Sperati, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686277/
https://www.ncbi.nlm.nih.gov/pubmed/29138984
http://dx.doi.org/10.1007/s11906-017-0797-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686277/
https://www.ncbi.nlm.nih.gov/pubmed/29138984
http://dx.doi.org/10.1007/s11906-017-0797-z

Ejemplares similares